Follow the people · Insider

JL

James Woodruff Lillie

Insider · Chief Scientific Officer · MPLT

James Woodruff Lillie files insider transactions with the SEC as a chief scientific officer of MapLight Therapeutics (MPLT). We hold 10 disclosed purchases and sales filed since 6 March 2018, 4 of them in the last 90 days.

  • Files forMPLT
  • Disclosed buys and sells10 in all, 4 in the last 90 days
  • Last disclosure19 August 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 27 October 202517 August 2026Chief Scientific Officer · MapLight Therapeutics (MPLT)30 Form 4 lines · source: SEC Form 4
  • Filed 10 May 201810 May 2018Chief Scientific Officer · Millendo Therapeutics (MLND)1 Form 4 line · source: SEC Form 4
  • Filed 6 March 20186 March 2018Chief Scientific Officer · OvaScience (OVAS)1 Form 4 line · source: SEC Form 4

Everything they disclosed

32 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.